The prospect of therapeutic antibody targeting IL-6 receptor

被引：0
|
作者：
Nishimoto, Norihiro [1 ]
机构：
[1] Osaka Univ, Grad Sch, Lab Immune Regulat, Suita, Osaka 5650871, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：27P / 27P
页数：1
相关论文
共 50 条
  • [1] ANTIMURINE IL-6 RECEPTOR ANTIBODY INHIBITS IL-6 EFFECTS INVIVO
    SUZUKI, H
    YASUKAWA, K
    SAITO, T
    ANZAI, M
    GOITSUKA, R
    HASEGAWA, A
    OHSUGI, Y
    TAGA, T
    KISHIMOTO, T
    IMMUNOLOGY LETTERS, 1991, 30 (01) : 17 - 22
  • [2] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
    Ali Berkant Avci
    Eugen Feist
    Gerd Rüdiger Burmester
    BioDrugs, 2018, 32 : 531 - 546
  • [3] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
    Avci, Ali Berkant
    Feist, Eugen
    Burmester, Gerd Ruediger
    BIODRUGS, 2018, 32 (06) : 531 - 546
  • [4] Therapeutic targeting of IL-6 trans-signaling
    Rose-John, Stefan
    CYTOKINE, 2021, 144
  • [5] IL-6 AND IL-6 RECEPTOR
    MURAKAMI, M
    HIRANO, T
    SEIKAGAKU, 1990, 62 (01): : 32 - 35
  • [6] The role and therapeutic targeting of IL-6 in rheumatoid arthritis
    Narazaki, Masashi
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (06) : 535 - 551
  • [7] UMINESCE: Phase 3 study of satralizumab, a therapeutic recycling antibody targeting the IL-6 receptor, in patients with generalised myasthenia gravis
    Kaminski, H.
    Zhao, C.
    zu Horste, G. Meyer
    O'Connor, K.
    Klingelschmitt, G.
    Krumova, P.
    Bolt, S.
    Vodopivec, I.
    Murai, H.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S80 - S81
  • [8] Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor
    Zia, Komal
    Nur-e-Alam, Mohammad
    Ahmad, Aftab
    Ul-Haq, Zaheer
    MOLECULAR DIVERSITY, 2024,
  • [9] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
    Ali Berkant Avci
    Eugen Feist
    Gerd R. Burmester
    BioDrugs, 2024, 38 : 61 - 71
  • [10] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
    Avci, Ali Berkant
    Feist, Eugen
    Burmester, Gerd R.
    BIODRUGS, 2024, 38 (01) : 61 - 71
12345